Health Care: Drugs

Agenus Inc (AGEN: NASDAQ)

$3.5 -0.06 | -1.69%
05/25/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 22.57M 24.82M 6.98M 3.05M
Cost of Sales 0.00 0.00 0.00 536.12K
Gross Operating Profit 22.57M 24.82M 6.98M 2.51M
Selling, General, and Administrative Expenses 33.13M 28.37M 21.25M 14.48M
Research & Development 94.97M 70.44M 22.35M 13.01M
Operating Income before D & A (EBITDA) -105.52M -74.00M -36.62M -24.98M
Depreciation & Amortization 4.95M 1.96M 1.58M 586.34K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -2.20M -5.97M 2.10M -2.67M
Special Income / Charges -1.95M -6.70M -6.70M 0.00
Total Income Before Interest Expenses (EBIT) -114.63M -88.63M -42.81M -28.24M
Interest Expense 17.32M 6.60M 1.26M 2.42M
Pre-Tax Income -131.94M -95.23M -44.07M -30.66M
Income Taxes 0.00 -5.39M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -127.00M -87.88M -42.49M -30.07M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -127.00M -87.88M -42.49M -30.07M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -127.00M -87.88M -42.49M -30.07M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-125.04M -81.18M -35.79M -30.07M
Preferred Dividends
Net Income Available To Common -127.20M -88.08M -42.69M -33.23M
Basic EPS from Continuing Ops. -1.46 -1.13 -0.71 -1.12
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.46 -1.13 -0.71 -1.12
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.46 -1.13 -0.71 -1.12
Basic Normalized Net Income/Share -1.44 -1.04 -0.60 -1.12
EPS fr Continuing Ops. -1.46 -1.13 -0.71 -1.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.46 -1.13 -0.71 -1.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.46 -1.13 -0.71 -1.12
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.44 -1.04 -0.60 -1.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AGEN

Latest AGEN Headlines from TheStreet

More Financial News for AGEN

Press Releases for AGEN

See All Press Releases

Partner Headlines for AGEN

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter